Post Facial Restructuring Bariatric Surgery: Case Report

Aims: According to the World Health Organization (WHO), obesity is considered a chronic, progressive, and relapsing disease that poses an excessive health risk. One of the proposed treatments for obesity is bariatric surgery. However, one of the consequences of this rapid weight loss due to surgery is fat loss in the face, which is associated with facial aging.

Presentation of Case: In 2020, a 57-year-old female patient complained of loss of volume and a sagging face. In 2018, the patient underwent bariatric surgery (25% weight reduction). Treatment was carried out with injectables from 2020-22, based on calcium hydroxyapatite, poly-L-lactic acid (PLLA), hyaluronic acid (HA), and botulinum toxin (TxA) type A.

Discussion: Autologous fat grafting offers good long-term results in patients with midface deficiency. Conversely, a disadvantage concerns the fat maintenance range of 20% to 80% (unpredictable number of cells surviving). In the present study, the patient preferred non-autologous injectable fillers over surgeries and autologous grafts in treating tissue sagging.

Conclusion Combined therapies provide facial volumetric replacement and improve sagging. They directly impact the self-perception and quality of life of patients who have undergone bariatric surgery using minimally invasive approaches and performed fractionally without the need for facial surgery.